Trial of Erlotinib in Patients With JAK-2 V617F Positive Polycythemia Vera

NCT01038856 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped The study was terminated by the sponsor

Conditions

Polycythemia Vera

Interventions

DRUG: Erlotinib

Sponsor

University of Oklahoma

Collaborators

[object Object]